Answers are grounded in this paper and cite their sources.
Actinomycin D is an antibiotic which was isolated from cultures of Streptomyces parvallus by Manaker et al., 1 in 1954. In 1957, Bullock and Johnson 2 elucidated the structure of this compound (Fig. 1). Actinomycin D has been shown to inhibit bacterial growth, 3-5 to produce cytotoxic changes in tissue cultures of neoplastic cells, 6 and to have antineoplastic activity against several animal tumors. 7-9 In human trials, regressions of Wilms' tumors, neuroblastomas, embryonal rhabdomyosarcomas, and other childhood sarcomas have been reported. 10-12 An occasional antitumor response has been noted in adult patients with malignancies, but the results in this age group have generally been disappointing. 11,13,14 Actinomycin D is of interest in cancer chemotherapy for several reasons. On a weight basis, it is the most active antitumor agent now available. The structural formula of this agent is unrelated to any other type of antitumor agent now known, indicating that
No takes yet. Share an insight, caveat, or question.
Richard K. Shaw (1960) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: